Search

Search Constraints

You searched for: Author/Creator Saw, Robyn P.M.

Search Results

1. 5‐Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. (6th February 2017)

2. Clinical outcomes following surgical treatment of lentigo maligna of the head and neck. Issue 5 (May 2021)

3. Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients. (1st January 2020)

5. Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients. (1st February 2019)

6. Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread. Issue 4 (13th May 2022)

7. Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma. (May 2021)

9. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. (August 2021)

10. Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases. Issue 4 (August 2020)